In vitro effects of dual wavelength photobiomodulation on monocytic response in painful temporomandibular disorder
Maria Gabriela Rodriguez, Mathew Warchol, Selenia Rubio, Patricia Cabrera, Rory Reever, Sherif Hosney, Cesar A Migliorati, Frank C Gibson III, Richard Ohrbach, Roger B Fillingim, Shannon Wallet, Margarete C Ribeiro Dasilva · 2025
Read In vitro effects of dual wavelength photobiomodulation on monocytic response in painful temporomandibular disorder by Maria Gabriela Rodriguez, Mathew Warchol, Selenia Rubio, Patricia Cabrera, Rory Reever, Sherif Hosney, Cesar A Migliorati, Frank C Gibson III, Richard Ohrbach, Roger B Fillingim, Shannon Wallet, Margarete C Ribeiro Dasilva (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12727183.txt.
Description
Maria Gabriela Rodriguez and eleven co-authors present a 2025 lab study of light therapy on immune cells from people with painful jaw joint disorder. The disorder is a common source of lasting face pain, and drug relief is often weak or harsh. Shining near infrared light on tissue, called photobiomodulation, may calm inflammation.
The team drew monocytes, a white blood cell type, from sixteen patients in a placebo controlled trial. Cells got a bacterial trigger, with or without a two wavelength light routine given every other day, four times. The study reads how the light changed the cells' inflammatory response. Results could guide light dosing in future care.
Catalog record
| CREATOR | Maria Gabriela Rodriguez, Mathew Warchol, Selenia Rubio, Patricia Cabrera, Rory Reever, Sherif Hosney, Cesar A Migliorati, Frank C Gibson III, Richard Ohrbach, Roger B Fillingim, Shannon Wallet, Margarete C Ribeiro Dasilva |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |